Close

Baird Maintains an 'Outperform' on Onyx Pharmaceuticals (ONXX); Hitting Pay Dirt on Bayer Settlement and Nexavar Restructuring Oct 12, 2011 01:19PM
Pre-Open Movers 9/15 (TSPT) (FNDT) (NCT) Higher; (CISG) (NFLX) (UBS) Lower (more...) Sep 15, 2011 09:34AM
Global Pharmaceuticals: Global Therapeutic Conference 2011: Focus on Real-World Medicine May 16, 2011 02:05PM
Barclays Maintains an 'Overweight' on Onyx Pharmaceuticals (ONXX); Implications of FOCUS Trial Changes Mar 29, 2011 01:26PM
Barclays Reiterates an 'Overweight' on Onyx Pharmaceuticals (ONXX); Nexavar Growth, CFZ Potential Outweigh Spend Feb 24, 2011 01:35PM


Feb 3, 2011 01:48PM Barclays Maintains an 'Overweight' on Onyx Pharmaceuticals (ONXX); Amended CFZ Deal Provides Incentive for Timely Filing
Dec 17, 2010 03:02PM Barclays Reiterates an 'Overweight' on Onyx Pharmaceuticals (ONXX); BATTLE-2 Now Includes Nexavar
Dec 15, 2010 09:25AM Daily State of the Markets 12/15: Missing The Point?
Dec 13, 2010 02:01PM Barclays Reiterates an 'Overweight' on Onyx Pharmaceuticals (ONXX); Significant Option Value on Pipeline Review
Dec 8, 2010 01:04PM Barclays Reiterates an 'Overweight' Rating on Onyx Pharmaceuticals (ONXX); Broadening Support for CFZ at ASH
Oct 4, 2010 01:52PM Barclays on U.S. Biotechnology Weekly: Focus on 4Q10 Picks
Sep 27, 2010 01:15PM Barclays on U.S. Biotechnology Weekly: Still Early in Biotech Upside Trade
Sep 9, 2010 03:37PM Barclays Maintains an 'Overweight' Rating on Onyx Pharmaceuticals (ONXX); Thoughts on Ono Pharma Deal
Sep 7, 2010 01:29PM Barclays on U.S. Biotechnology Weekly: Significant Option Value Before Key Events
Aug 30, 2010 01:45PM Barclays Maintains an 'Overweight' on Onyx Pharmaceuticals (ONXX); Limited Read-through From T-DM1 to CFZ
Jul 26, 2010 01:02PM Unusual 11 Mid-Day Movers 07/26: ASTC, ONXX, CIGX, IDSA, AONE, DSTI Higher; CART, NED, CSR, RST, FIBK Lower
Jul 26, 2010 10:06AM Morning Movers 7/26: ASTC, DPTR, ONXX, AONE, ARNA Higher; CART, NED, DSTI Lower
Jul 12, 2010 01:42PM Barclays Maintains an 'Overweight' on Onyx Pharmaceuticals (ONXX); Target Reduced, Prospects Still Bright
Aug 7, 2009 07:07AM Onyx Pharmaceuticals (ONXX) Sells 4M Shares at $30.50, $200M Conv Noves
May 20, 2009 01:12PM Barclays Gets Bullish On US Biotechnology Sector (BBH)